| 摘要 |
The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO188, PRO235, PRO266, PRO337, PRO361, PRO539, PRO698, PRO717, PRO846, PRO874, PRO98346, PRO1082, PRO1097, PRO1192, PRO1268, PRO1278, PRO1303, PRO1308, PRO1338, PRO1378, PRO1415, PRO1867, PRO1890, PRO3438, PRO19835, PRO36915, PRO36029, PRO4999, PRO5778, PRO5997, PRO6079, PRO6090, PRO7178, PRO21184, PRO7434, PRO9822, PRO9833, PRO9836, PRO9854, PRO9862, PRO10284, PRO37510, PRO35444, PRO20473, PRO21054 or PRO35246 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities. |
| 申请人 |
GENENTECH, INC.;LEXICON PHARMACEUTICALS, INC.;BOLLINGER, KRISTI RAE;HORNER, ALLISON ANNE BYERS;COMBS, KATHERIN, E.;CULBERTSON, LING LING;CUNNINGHAM, JAIME-JO;DESAUVAGE, FREDERIC;EDWARDS, JOEL;GIRGIS, ROSEMARY;GREEN, LESLIE;MCLAIN, DINA REBECCA;MINZE, LAURIE JEANETTE;MONTGOMERY, CHARLES, A.;PAYNE, BOBBY JOE;PHILLIPS, HEIDI;SHI, ZHENG-ZHENG;SPARKS, MARY JEAN;STALA, JOY;TANG, TRACY TZU-LING;TOWNSEND, TERESA GAIL;VOGEL, PETER;SEVAUX, TRACY ELLEN WILLIS |
发明人 |
BOLLINGER, KRISTI RAE;HORNER, ALLISON ANNE BYERS;COMBS, KATHERIN, E.;CULBERTSON, LING LING;CUNNINGHAM, JAIME-JO;DESAUVAGE, FREDERIC;EDWARDS, JOEL;GIRGIS, ROSEMARY;GREEN, LESLIE;MCLAIN, DINA REBECCA;MINZE, LAURIE JEANETTE;MONTGOMERY, CHARLES, A.;PAYNE, BOBBY JOE;PHILLIPS, HEIDI;SHI, ZHENG-ZHENG;SPARKS, MARY JEAN;STALA, JOY;TANG, TRACY TZU-LING;TOWNSEND, TERESA GAIL;VOGEL, PETER;SEVAUX, TRACY ELLEN WILLIS |
